The DOI matches its Crossref record; 435 of the 435 references it cites were found in a registry or an index.
Colorectal liver metastasis: molecular mechanism and interventional therapy
Open accessAbstract
Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a high morbidity additionally, CRC patients may develop liver metastasis, which is the major cause of death. Despite significant advances in diagnostic and therapeutic techniques, the survival rate of colorectal liver metastasis (CRLM) patients remains very low. CRLM, as a complex cascade reaction process involving multiple factors and procedures, has complex and diverse molecular mechanisms. In this review, we summarize the mechanisms/pathophysiology, diagnosis, treatment of CRLM. We also focus on an overview of the recent advances in understanding the molecular basis of CRLM with a special emphasis on tumor microenvironment and promise of newer targeted therapies for CRLM, further improving the prognosis of CRLM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“only 45% can be resected with current methodology.”
From First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure (2024) · cites this paper as [43]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of the approximately 1 million patients diagnosed worldwide with colorectal cancer liver metastases each year,43”
From First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure (2024) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
7 retracted
Items 201–400 of 435
Kopitz, C., Gerg, M., Bandapalli, O. R., Ister, D., Pennington, C. J., Hauser, S., Flechsig, C., Krell, H., Antolovic, D., Brew, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0232 · Cited by 153
Xu, J., Xiao, Y., Liu, B., Pan, S., Liu, Q., Shan, Y., Li, S., Qi, Y., Huang, Y., & Li, J. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01562-6 · Cited by 153
AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
Jackstadt, R., Röh, S., Neumann, J. H. L., Jung, P., Hoffmann, R. F. G., Horst, D. A., Berens, C., Bornkamm, G. W., Kirchner, T., Menssen, A., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20120812 · Cited by 152
A New X-Ray Activated Nanoparticle Photosensitizer for Cancer Treatment
Ma, L., Zou, X., & Chen, W. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1954 · Cited by 150
Self-citationCurcumin: New Insights into an Ancient Ingredient against Cancer
Willenbacher, E., Khan, S. Z., Altuna, S. C., Trapani, D., Hussain, S., Wolf, D. G. F., Willenbacher, W., Spizzo, G., & Seeber, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081808 · Cited by 150
Ji, D., Chen, Z., Li, M., Zhan, T., Yao, Y., Zhang, Z., Xi, J., Li, Y., & Gu, J. F. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-86 · Cited by 149
Datta, J., Narayan, R. R., Kemeny, N. E., & D'Angelica, M. I. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.1694 · Cited by 148
Cell elasticity with altered cytoskeletal architectures across multiple cell types
Grady, M. E., Composto, R. J., & Eckmann, D. M. (2016) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2016.01.022 · Cited by 146
Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers
Wang, J., Day, R. B., Dong, Y., Weintraub, S. J., & Michel, L. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2003 · Cited by 145
Yamada, N. O., Kuranaga, Y., Kumazaki, M., Shinohara, H., Taniguchi, K., & Akao, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.7041 · Cited by 145
Ogawa, R., Yamamoto, T. S., Hirai, H., Hanada, K., Kiyasu, Y., Nishikawa, G., Mizuno, R., Inamoto, S., Itatani, Y., Sakai, Y., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3684 · Cited by 144
Katz, S. C., Pillarisetty, V. G., Bamboat, Z. M., Shia, J., Hedvat, C. V., Gönen, M., Jarnagin, W. R., Fong, Y., Blumgart, L. H., D'Angelica, M. I., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0585-3 · Cited by 143
The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T. S., Ogawa, R., Taketo, M. M., & Sakai, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050643 · Cited by 140
Inamoto, S., Itatani, Y., Yamamoto, T. S., Minamiguchi, S., Hirai, H., Iwamoto, M., Hasegawa, S., Taketo, M. M., Sakai, Y., & Kawada, K. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0726 · Cited by 137
Meng, X., Wu, J., Pan, C., Wang, H., Ying, X., Zhou, Y., Yu, H., Zuo, Y., Pan, Z., Liu, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.004 · Cited by 137
Geng, Y., Zheng, X. W., Hu, W., Wang, Q., Xu, Y., He, W., Wu, C., Zhu, D., Wu, C., & Jiang, J. (2019) · Clinical Science · doi:10.1042/cs20190286 · Cited by 132
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
Ling, H. Y., Pickard, K. M., Ivan, C., Isella, C., Ikuo, M., Mitter, R., Spizzo, R., Bullock, M. D., Braicu, C., Pileczki, V., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309372 · Cited by 131
Ding, Q., Chang, C.-J., Xie, X., Xia, W., Yang, J.-Y., Wang, S., Wang, Y., Xia, J., Chen, L., Cai, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45008 · Cited by 130
Self-citationla Fuente, M. D., Landskron, G., Parada, D., Dubois‐Camacho, K., Simian, D., Martínez, M., Romero, D., Roa, J. C., Chahuán, I., Gutierrez, R. G. R., et al. (2018) · Tumor Biology · doi:10.1177/1010428318810059 · Cited by 130
Grossman, J. G., Nywening, T. M., Belt, B. A., Panni, R. Z., Krasnick, B. A., DeNardo, D. G., Hawkins, W. G., Goedegebuure, S. P., Linehan, D. C., & Fields, R. C. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1470729 · Cited by 128
Li, J., Du, L., Yang, Y., Wang, C., Liu, H., Wang, L., Zhang, X., Li, W., Zheng, G., & Dong, Z. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.019 · Cited by 127
Li, Y., Sun, Z., Liu, B., Shan, Y., Zhao, L., & Li, J. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.281 · Cited by 127
Jiang, K., Chen, H., Fang, Y., Chen, L., Zhong, C., Bu, T., Dai, S., Pan, X., Fu, D., Qian, Y., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01816-3 · Cited by 127
Current status and future perspectives on treatment of liver metastasis in colorectal cancer
Bandar, M. H. A., & Kim, N. K. (2017) · Oncology Reports · doi:10.3892/or.2017.5531 · Cited by 126
Shang, A., Gu, C., Zhou, C., Yang, Y., Chen, C., Zeng, B., Wu, J., Lu, W., Wang, W., Sun, Z., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0517-1 · Cited by 126
Chen, D.-L., Wang, Z.-Q., Zeng, Z.-L., Wu, W.-J., Zhang, D.-S., Luo, H., Wang, F., Qiu, M., Wang, D., Ren, C., et al. (2014) · Hepatology · doi:10.1002/hep.27118 · Cited by 125
Shi, L., Jackstadt, R., Siemens, H., Li, H., Kirchner, T., & Hermeking, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2203 · Cited by 125
Takahashi, N. K., Kawanishi‐Tabata, R., Haba, A., Tabata, M., Haruta, Y., Tsai, H., & Seon, B. K. (2001) · PubMed · Cited by 123
Ericson, K., Gan, C. M., Cheong, I., Rago, C., Samuels, Y., Velculescu, V. E., Kinzler, K. W., Huso, D. L., Vogelstein, B., & Papadopoulos, N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914018107 · Cited by 122
Tan, H., Gong, W.-Z., Zhou, K., Xiao, Z., Hou, F., Huang, T., Zhang, L., Dong, H., Zhang, W.-L., Liu, Y., et al. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1685157 · Cited by 119
Jag2‐Notch1 signaling regulates oral epithelial differentiation and palate development
Casey, L. M., Lan, Y., Cho, E., Maltby, K. M., Gridley, T., & Jiang, R. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20821 · Cited by 118
Siddiqui, I., Erreni, M., van Brakel, M., Debets, R., & Allavena, P. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0125-1 · Cited by 118
Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis
Zheng, J., Yang, M. H., Shao, J., Miao, Y.-J., Han, J., & Du, J. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-141 · Cited by 118
Zhuang, M., Zhao, S., Jiang, Z., Wang, S., Sun, P., Quan, J., Yan, D., & Wang, X. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.049 · Cited by 118
Zhao, S., Venkatasubbarao, K., Lazor, J. W., Sperry, J. C., Jin, C., Cao, L., & Freeman, J. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5123 · Cited by 115
Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p
Li, H., & Li, F. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0254-z · Cited by 113
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
Tellez-Gabriel, M., Heymann, M., & Heymann, D. (2019) · Theranostics · doi:10.7150/thno.34337 · Cited by 112
A New Modality for Cancer Treatment—Nanoparticle Mediated Microwave Induced Photodynamic Therapy
Yao, M., Ma, L., Li, L., Zhang, J., Lim, R. X., Chen, W., & Zhang, Y. (2016) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2016.2322 · Cited by 111
Self-citationWu, D., Weinan, X., Li, X., Yu, Z.-W., Gu, X.-Y., Jinxue, T., & Li, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1707-x · Cited by 110
Sun, L., Liu, X., Pan, B., Hu, X., Zhu, Y., Su, Y., Guo, Z., Zhang, G., Xu, M., Xu, X., et al. (2019) · Journal of Cancer · doi:10.7150/jca.33022 · Cited by 110
Bigagli, E., Luceri, C., Guasti, D., & Cinci, L. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1219815 · Cited by 109
Wang, Y., Lu, Z., Wang, N., Feng, J., Zhang, J., Luan, L., Zhao, W., & Zeng, X. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0082-5 · Cited by 108
Self-citationTSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche
Yamamoto, M., Kikuchi, H., Ohta, M., Kawabata, T., Hiramatsu, Y., Kondo, K., Baba, M., Kamiya, K., Tanaka, T., Kitagawa, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1748 · Cited by 105
Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b
Xu, X., Zheng, B., Hu, Z., Qian, Z., Huang, C., Liu, X., & Wu, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21748 · Cited by 104
Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes
Sun, B., Zhou, Y., Fang, Y., Li, Z., Gu, X., & Xiang, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.32196 · Cited by 104
Xu, J., Shao, T., Song, M., Xie, Y., Zhou, J., Yin, J., Ding, N., Zou, H., Li, Y., & Zhang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01174-w · Cited by 103
Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention
Jafri, M., Al-Qahtani, M. H., & Shay, J. W. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.004 · Cited by 102
Chen, L., Zhi, Z., Wang, L. Y., Zhao, Y., Deng, M., Liu, Y., Yan, Q., Tian, M., Liu, Y., Shen, T., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5238 · Cited by 102
Li, J., Xia, L., Zhou, Z., Zuo, Z., Xu, C., Song, H., & Cai, J. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.01.002 · Cited by 101
Dong, X., Yang, Z., Yang, H., Li, D., & Qiu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00160 · Cited by 101
Aggregation-induced emission luminogens for highly effective microwave dynamic therapy
Pandey, N. K., Xiong, W. H., Wang, L., Chen, W., Bui, B., Yang, J. Y., Amador, E. H., Chen, M., Xing, C., Athavale, A., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.031 · Cited by 101
Self-citationLiu, Y., Zhang, Y., Wu, H., Li, Y., Zhang, Y., Liu, M., Li, X., & Tang, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.61 · Cited by 100
Liu, H., Liu, Y., Sun, P., Leng, K., Xu, Y., Mei, L., Han, P., Zhang, B., Yao, K., Li, C., et al. (2020) · Clinical Science · doi:10.1042/cs20191087 · Cited by 99
Nanoparticle Self-Lighting Photodynamic Therapy for Cancer Treatment
Chen, W. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.001 · Cited by 98
Self-citationFiegle, E., Doleschel, D., Koletnik, S., Rix, A., Weiskirchen, R., Borkham‐Kamphorst, E., Kiessling, F. M., & Lederle, W. (2019) · Neoplasia · doi:10.1016/j.neo.2019.07.006 · Cited by 98
Cheng, X., Lu, X.-X., Guo, P.-D., Shen, T., Zhang, S., He, X., Gan, W.-J., Li, X., Wang, J., Zhao, Y., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3595 · Cited by 97
Exploration of Graphitic-C3N4 Quantum Dots for Microwave-Induced Photodynamic Therapy
Chu, X., Li, K. C., Guo, H., Zheng, H., Shuda, S., Wang, X., Zhang, J., Chen, W., & Zhang, Y. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00110 · Cited by 96
Self-citationXia, Y., He, J., Zhang, H., Wang, H., Tetz, G. V., Maguire, C. A., Wang, Y., Onuma, A. E., Genkin, D. D., Tetz, V., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12787 · Cited by 95
Self-citationSelection for surgery and survival of synchronous colorectal liver metastases; a nationwide study
Norén, A., Eriksson, H. G., & Olsson, L. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.10.055 · Cited by 94
Hammill, C. W., Billingsley, K. G., Cassera, M. A., Wolf, R., Ujiki, M. B., & Hansen, P. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1535-9 · Cited by 93
A new Cu–cysteamine complex: structure and optical properties
Ma, L., Chen, W., Schatte, G., Wang, W. D., Joly, A. G., Huang, Y., Ramaswami Sammynaiken, A., & Hossu, M. (2014) · Journal of Materials Chemistry C · doi:10.1039/c4tc00114a · Cited by 91
Self-citationLiang, J., Chen, M., Hughes, D. T., Chumanevich, A. A., Altilia, S., Kaza, V., Lim, C., Kiaris, H., Mythreye, K., Peña, M. M. O., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1583 · Cited by 91
Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D., Zhang, R., Ebert, M., Chen, J., Wong, B. C., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.137 · Cited by 90
Laudato, S., Patil, N., Abba, M. L., Leupold, J. H., Benner, A., Gaiser, T., Marx, A., & Allgayer, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30854 · Cited by 90
Gordon-Weeks, A. N., Lim, S. Y., Yuzhalin, A. E., Lucotti, S., Vermeer, J. A. F., Jones, K. I., Chen, J., & Muschel, R. J. (2019) · Cancers · doi:10.3390/cancers11050630 · Cited by 90
CircFNDC3B sequestrates miR‐937‐5p to derepress TIMP3 and inhibit colorectal cancer progression
Zeng, W., Liu, Y., Li, W., Li, Y., & Zhu, J. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12796 · Cited by 90
Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells
Al-Aidaroos, A. Q., Yuen, H. F., Guo, K., Zhang, S., Chung, T., Chng, W. J., & Zeng, Q. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66824 · Cited by 89
MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1
Song, M., Yin, Y., Zhang, J., Zhang, B., Bian, Z., Quan, C., Zhou, L., Hu, Y., Wang, Q., Ni, S., et al. (2014) · Protein & Cell · doi:10.1007/s13238-014-0093-5 · Cited by 88
Komatsu, K., Kobune-Fujiwara, Y., Andoh, A., Ishiguro, S., Hunai, H., Suzuki, N., Kameyama, M., Murata, K., Miyoshi, J., Akedo, H., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1356 · Cited by 87
PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
Guo, K., Li, J., Wang, H., Osato, M., Tang, J. P., Quah, S. Y., Gan, B. Q., & Zeng, Q. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0726 · Cited by 87
Lin, Q., Ren, L., Jian, M., Xu, P., Li, J., Zheng, P., Feng, Q., Yang, L., Ji, M., Wei, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1922-5 · Cited by 86
Zhao, Z., Zou, S., Guan, X., Wang, M., Jiang, Z., Liu, Z., Li, C., Lin, H., Liu, X., Yang, R., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00650 · Cited by 85
Self-citationMicroRNA‐143‐3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3
Guo, L., Fu, J., Sun, S., Zhu, M., Zhang, L., Niu, H., Chen, Z., Zhang, Y., Guo, L., & Wang, S. (2018) · Cancer Science · doi:10.1111/cas.13910 · Cited by 84
MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer
Kim, T. W., Lee, Y. S., Yun, N. H., Shin, C. H., Hong, H. K., Kim, H. H., & Cho, Y. B. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0940-5 · Cited by 84
Pandey, N. K., Chudal, L., Phan, J. B., Lin, L., Johnson, O., Xing, M., Liu, J. P., Li, H., Huang, X., Shu, Y., et al. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01566c · Cited by 83
Self-citationLiu, B., Liu, Q., Pan, S., Huang, Y., Qi, Y., Li, S., Xiao, Y., & Li, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1468-5 · Cited by 83
miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR
Li, W., Chang, J., Wang, S., Liu, X., Peng, J., Huang, D., Sun, M., Chen, Z., Zhang, W., Guo, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4423 · Cited by 82
Donadon, M., Hudspeth, K. L., Cimino, M., Tommaso, L. D., Preti, M., Tentorio, P., Roncalli, M. G., Mavilio, D., & Torzilli, G. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3446-6 · Cited by 82
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients
Wyss, J., Dislich, B., Koelzer, V. H., Galván, J. A., Dawson, H., Hädrich, M., Inderbitzin, D., Lugli, A., Zlobec, I., & Berger, M. D. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.09.007 · Cited by 82
Zhang, W., Zhang, X., Shen, Y., Shi, F., Song, C., Liu, T., Gao, P., Lan, B., Liu, M., Wang, S., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.001 · Cited by 82
Ni, X., Ding, Y., Yuan, H., Shao, J., Yan, Y., Guo, R., Luan, W., & Xu, M. (2019) · Cell Proliferation · doi:10.1111/cpr.12723 · Cited by 81
Cellura, D., Pickard, K., Quaratino, S., Parker, H., Strefford, J. C., Thomas, G. J., Mitter, R., Mirnezami, A. H., & Peake, N. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0466 · Cited by 80
Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203
Wang, L., Wei, Z., Wu, K., Dai, W., Zhang, C., Peng, J., & He, Y. (2018) · Aging · doi:10.18632/aging.101628 · Cited by 80
Chen, X., Liu, J., Li, Y., Pandey, N. K., Chen, T., Wang, L., Amador, E. H., Chen, W., Liu, F., Xiao, E., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.016 · Cited by 80
Self-citationRole of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
Demková, L., & Kučerová, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0795-z · Cited by 79
Liu, Z., Xiong, L., Ouyang, G., Ma, L., Sahi, S. K., Wang, K., Lin, L., Huang, H., Miao, X., Chen, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09375-y · Cited by 79
Self-citationMehta, C. R., Liu, L., & Theuer, C. P. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy464 · Cited by 78
Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer
Mokutani, Y., Uemura, M., Munakata, K., Okuzaki, D., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Murata, K., Takemasa, I., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5133-3 · Cited by 78
Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties.
Dhanabal, M., LaRochelle, W. J., Jeffers, M., Herrmann, J. L., Rastelli, L., McDonald, W. F., Chillakuru, R. A., Yang, M., Boldog, F. L., Padigaru, M., et al. (2002) · PubMed · Cited by 78
Zhou, G., Noordam, L., Sprengers, D., Doukas, M., Boor, P. P. C., van Beek, A. A., Erkens, R. G. A., Mancham, S., Grünhagen, D. J., Menon, A. G., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1448332 · Cited by 77
Rezaei, R., Baghaei, K., Amani, D., Piccin, A., Hashemi, S. M., Aghdaei, H. A., & Zali, M. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119035 · Cited by 77
Stiegelbauer, V., Vychytilova‐Faltejskova, P., Karbiener, M., Pehserl, A.-M., Reicher, A., Resel, M., Heitzer, E., Ivan, C., Bullock, M. D., Ling, H. Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0023 · Cited by 75
Lan, Q., Wei, L., Zeng, Y., Liu, L., Li, S., Jin, S., Zhang, Y., Luo, X., Xu, H., Lin, X., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0507 · Cited by 73
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
Kasprzak, A., & Adamek, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123887 · Cited by 73
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
Paauwe, M., Heijkants, R. C., Oudt, C. H., van Pelt, G. W., Cui, C., Theuer, C. P., Hardwick, J. C. H., Sier, C. F. M., & Hawinkels, L. J. A. C. (2016) · Oncogene · doi:10.1038/onc.2015.509 · Cited by 72
THBS1 facilitates colorectal liver metastasis through enhancing epithelial–mesenchymal transition
Liu, X., Xu, D., Liu, Z., Li, Y., Zhang, C., Gong, Y., Jiang, Y., & Xing, B. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02308-8 · Cited by 71
Self-citationHirai, H., Fujishita, T., Kurimoto, K., Miyachi, H., Kitano, S., Inamoto, S., Itatani, Y., Saitou, M., Maekawa, T., & Taketo, M. M. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9684-z · Cited by 69
Zhang, Q., Guo, X., Cheng, Y., Chudal, L., Pandey, N. K., Zhang, J., Ma, L., Xi, Q., Yang, G., Chen, Y., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0156-4 · Cited by 68
Self-citationPalmieri, V., Lazaris, A., Mayer, T. Z., Petrillo, S. K., Alamri, H., Rada, M., Jarrouj, G., Park, W., Gao, Z., McDonald, P. P., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5449 · Cited by 64
Komatsu, K., Murata, K., Kameyama, M., Ayaki, M., Mukai, M., Ishiguro, S., Miyoshi, J., Tatsuta, M., Inoue, M., & Nakamura, H. (2002) · Oncology · doi:10.1159/000063812 · Cited by 64
Wang, P., Wang, X., Ma, L., Sahi, S. K., Li, L., Wang, X., Wang, Q., Chen, Y., Chen, W., & Liu, Q. (2018) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201700378 · Cited by 64
Self-citationHsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer
Wang, Y., Xuan, Z., Baocheng, W., Zhang, D., Zhang, C., & Yueming, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.085 · Cited by 64
Self-citationChen, Z., Qi, J.-J., Wu, Q., Lu, J., Liu, Z., Wang, Y., Hu, P., Li, T., Lin, J., Wu, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1178-z · Cited by 64
Self-citationvan den Bulk, J., Verdegaal, E. M. E., Ruano, D., Ijsselsteijn, M. E., Visser, M., van der Breggen, R., Duhen, T., van der Ploeg, M., de Vries, N. L., Oosting, J., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0697-8 · Cited by 63
Li, E., Yang, X., Du, Y., Wang, G., Chan, D. W., Wu, D., Xu, P., Ni, P., Xu, D., & Hu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667177 · Cited by 63
Zhou, T., Wu, L., Ma, N., Tang, F., Yu, Z., Jiang, Z., Li, Y., Zong, Z., & Hu, K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03273-4 · Cited by 63
Zhang, T., Guo, J., Gu, J., Wang, Z., Wang, G., Li, H., & Wang, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6840 · Cited by 62
Exploration of TiO2 nanoparticle mediated microdynamic therapy on cancer treatment
Chu, X., Mao, L., Johnson, O., Li, K., Phan, J. B., Yin, Q., Li, L., Zhang, J., Chen, W., & Zhang, Y. X. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.02.016 · Cited by 62
Self-citationPedroza‐González, A., Zhou, G., Singh, S. P., Boor, P. P. C., Pan, Q., Grünhagen, D. J., de Jonge, J., Tran, T. K., Verhoef, C. K., IJzermans, J. N. M., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1051297 · Cited by 61
miR-30bregulates migration and invasion of human colorectal cancer via SIX1
Zhao, H., Xu, Z., Qin, H., Gao, Z., & Gao, L. (2014) · Biochemical Journal · doi:10.1042/bj20131535 · Cited by 60
A Non‐rare‐Earth Ions Self‐Activated White Emitting Phosphor under Single Excitation
Guo, H., Zhang, J., Ma, L., Chavez, J. L., Yin, L., Gao, H. T., Tang, Z., & Chen, W. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201502641 · Cited by 60
Self-citationBrudvik, K. W., Henjum, K., Aandahl, E. M., Bjørnbeth, B. A., & Taskén, K. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1174-4 · Cited by 59
Bauer, T. W., Fan, F., Liu, W., Johnson, M., Parikh, N. U., Parry, G. C., Callahan, J. A., Mazar, A. P., Gallick, G. E., & Ellis, L. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000160699.59061.92 · Cited by 59
Ren, C., Zhang, Z., Wang, S., Zhu, W., Zheng, P., & Wang, W. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0350 · Cited by 59
NOTCH3 Signaling Regulates MUSASHI-1 Expression in Metastatic Colorectal Cancer Cells
Pastò, A., Serafin, V., Pilotto, G., Lago, C., Bellio, C., Trusolino, L., Bertotti, A., Hoey, T. C., Plateroti, M., Esposito, G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2022 · Cited by 58
Chu, P., Lin, P., Wu, H.-Y., Lin, K., Wu, C. S.-Y., Bekaii‐Saab, T., Lin, Y., Lee, C., Lee, J.-C., & Chen, C. (2018) · Oncogene · doi:10.1038/s41388-018-0222-3 · Cited by 57
Plasma Exosomal miRNA-139-3p is a Novel Biomarker of Colorectal Cancer
Liu, W., Yang, D., Chen, L., Liu, Q., Wang, W., Yang, Z., Shang, A., Quan, W., & Li, D. (2020) · Journal of Cancer · doi:10.7150/jca.45548 · Cited by 57
Tacchini, L., Matteucci, E., Ponti, C. D., & Desiderio, M. A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00348-3 · Cited by 56
Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis
Lu, M., Zessin, A. S., Glover, W., & Hsu, D. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169439 · Cited by 56
Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer
Yang, Y., Qu, A., Wu, Q., Zhang, X., Wang, L., Li, C., Dong, Z., Du, L., & Wang, C. (2020) · Aging · doi:10.18632/aging.102228 · Cited by 55
Wang, W., Yao, Y., Jiang, L., Hu, T., Ma, J., Ruan, Z., Tian, T., Guo, H., Wang, S., & Nan, K. (2013) · Disease Markers · doi:10.1155/2013/983981 · Cited by 53
Moore, A. E., Greenhough, A., Roberts, H. R., Hicks, D. J., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp183 · Cited by 53
Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer
Li, J., Chen, Y., Guo, X., Zhou, L., Jia, Z., Tang, Y., Lin, L., Liu, W., & Ren, C. (2016) · Tumor Biology · doi:10.1007/s13277-015-4396-9 · Cited by 52
Park, Y. R., Kim, S. L., Lee, M. R., Seo, S. Y., Lee, J. H., Kim, I. H., Kim, I. H., Lee, S. O., Lee, S. T., & Kim, S. W. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2440-4 · Cited by 52
Huang, L., Lin, H., Kang, L., Huang, P., Huang, J. C., Cai, J., Xian, Z., Zhu, P., Huang, M., Wang, L., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27456 · Cited by 52
Ding, Y., Hao, K., Li, Z., Ma, R., Zhou, Y. L., Zhou, Z., Wei, M., Liao, Y., Dai, Y., Yang, Y., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29317 · Cited by 52
Pan, S., Ren, F., Li, L., Liu, D.-H., Li, Y., Wang, A., Li, W., Dong, Y., & Guo, W. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111939 · Cited by 52
Shi, R., Chen, W., Yang, B., Qu, J., Cheng, Y., Zhu, Z., Gao, Y. J., Wang, Q., Liu, Y., Li, Z., et al. (2020) · PubMed Central · Cited by 52
Self-citationHalama, N., Spille, A., Lerchl, T., Brand, K., Herpel, E., Welte, S. E., Keim, S., Lahrmann, B., Klupp, F., Kahlert, C., et al. (2013) · OncoImmunology · doi:10.4161/onci.24116 · Cited by 51
SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET
Du, F., Li, X., Feng, W., Qiao, C., Chen, J., Jiang, M., Qiu, Z., Qian, M., Tian, D., Nie, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1233-4 · Cited by 51
miR-146a targets c-met and abolishes colorectal cancer liver metastasis
Bleau, A., Redrado, M., Nistal‐Villán, E., Villalba-Esparza, M., Expósito, F., Redín, E., de Aberasturi, A. L., Larzábal, L., Freire, J., Gómez‐Román, J., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.008 · Cited by 50
Li, S., Han, Z., Zhao, N., Zhu, B., Zhang, Q., Yang, X. F., Sheng, D., Hou, J., Guo, S., Wei, L., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.014 · Cited by 49
Circular RNA profiling identifies circ102049 as a key regulator of colorectal liver metastasis
Zhi, Q., Wan, D., Ren, R., Xu, Z., Guo, X., Han, Y., Liu, F., Xu, Y., Qin, L., & Wang, Y. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12840 · Cited by 49
Self-citationZhang, C., Wang, L., Jin, C., Zhou, J., Peng, C., Wang, Y., Xu, Z., Zhang, D., Huang, Y., Zhang, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03461-w · Cited by 49
Self-citationMACC1 mRNA Levels Predict Cancer Recurrence After Resection of Colorectal Cancer Liver Metastases
Isella, C., Mellano, A., Galimi, F., Petti, C., Capussotti, L., Simone, M. D., Bertotti, A., Médico, E., & Muratore, A. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31828f96bc · Cited by 48
Li, Z., Liu, J., Chen, H., Zhang, Y., Shi, H., Huang, L., Tao, J., Shen, R., & Wang, T. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz181 · Cited by 48
Ma, L., Qiao, H., He, C., Yang, Q., Cheung, C. H. A., Kanwar, J. R., & Sun, X. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9578-0 · Cited by 47
Zhang, Y., Sun, J., Qi, Y., Wang, Y., Ding, Y., Wang, K., Zhou, Q., Wang, J., Ma, F., Zhang, J., et al. (2020) · Aging · doi:10.18632/aging.103016 · Cited by 47
Self-citationQiu, Y., Yu, H., Shi, X., Xu, K., Tang, Q., Liang, B., Hu, S.-J., Bao, Y.-J., Xu, J., Cai, J., et al. (2016) · Cell Proliferation · doi:10.1111/cpr.12237 · Cited by 46
Wang, Y., Sun, J., Wei, X., Luan, L., Zeng, X., Wang, C., & Zhao, W. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s125724 · Cited by 46
Self-citationPan, Z., Peng, J., Lin, J., Chen, G., Wu, X., Lu, Z., Deng, Y., Zhao, Y., Sui, Q., & Wan, D. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0298-8 · Cited by 46
Huang, X., Wan, F., Ma, L., Phan, J. B., Lim, R. X., Li, C., Chen, J., Deng, J.-H., Li, Y., Chen, W., et al. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1564568 · Cited by 46
Self-citationGu, J., Wang, G., Liu, H., & Xiong, C. (2018) · Cell Proliferation · doi:10.1111/cpr.12455 · Cited by 46
L1 Cell Adhesion Molecule Is a Novel Therapeutic Target in Intrahepatic Cholangiocarcinoma
Min, J., Kim, J., Li, S., Lee, J. W., Yoon, H., Ryu, C. J., Jeon, S. H., Lee, J.-H., Kim, J. Y., Yoon, H. K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3075 · Cited by 45
Santasusagna, S., Moreno, I., Navarro, A., Martínez-Ródenas, F., Hernández, R., Castellano, J. J., Muñoz, C., & Monzó, M. (2018) · Oncology · doi:10.1159/000490726 · Cited by 45
Tutino, V., Nunzio, V. D., Caruso, M. G., Veronese, N., Lorusso, D., Masi, M. D., Benedetto, M. L., & Notarnicola, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082050 · Cited by 45
Arcaroli, J. J., Tai, W., McWilliams, R. R., Bagby, S. M., Blatchford, P. J., Varella‐Garcia, M., Purkey, A., Quackenbush, K. S., Song, E., Pitts, T. M., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29676 · Cited by 44
Cai, Y., Yan, P., Zhang, G., Yang, W., Wang, H., & Cheng, X. (2018) · Cancer Biomarkers · doi:10.3233/cbm-181503 · Cited by 44
Liu, J., Zhan, Y., Wang, J., Wang, J., Guo, J., & Kong, D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12819 · Cited by 44
Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis
Agarwal, E., Robb, C. M., Smith, L., Brattain, M. G., Wang, J., Black, J. D., & Chowdhury, S. (2017) · Oncogene · doi:10.1038/onc.2016.460 · Cited by 43
miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1
Li, W., Chen, A., Xiong, L., Chen, T., Tao, F., Lu, Y., He, Q., Zhao, L., Ou, R., & Xu, Y. (2017) · Tumor Biology · doi:10.1177/1010428317698389 · Cited by 43
Self-citationThe Effectiveness and Safety of X-PDT for Cutaneous Squamous Cell Carcinoma and Melanoma
Shi, L., Liu, P., Wu, J., Ma, L., Zheng, H., Antosh, M. P., Zhang, H., Wang, B., Chen, W., & Wang, X. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0094 · Cited by 43
Self-citationHong, Y., Xin, C., Zheng, H., Huang, Z., Yang, Y., Zhou, J.-D., Gao, X., Hao, L., Liu, Q., Zhang, W., et al. (2020) · Journal of Cancer · doi:10.7150/jca.42731 · Cited by 43
Li, C., & Zhou, H. (2020) · Cancer Medicine · doi:10.1002/cam4.3332 · Cited by 43
Self-citationEmerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
Yu, X., Zhu, L., Liu, J., Xie, M., Chen, J., & Li, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s271955 · Cited by 43
Tang, J., Zhang, C., Huang, Y., Wang, L., Xu, Z., Zhang, D., Zhang, Y., Peng, W., Feng, Y., & Sun, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03565-3 · Cited by 43
Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass
Valcz, G., Galamb, O., Krenács, T., Spisák, S., Kalmár, A., Patai, Á. V., Wichmann, B., Dede, K., Tulassay, Z., & Molnár, B. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.72 · Cited by 42
Luo, Y., Ouyang, J., Zhou, D., Zhong, S., Wen, M., Ou, W., Yu, H., Jia, L., & Huang, Y. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4915-9 · Cited by 42
Lee, S., Han, Y., Yun, J., Lee, C. W., Shin, D., Ha, Y., Kim, J., Koh, J. S., Hong, S., Han, D. C., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27381 · Cited by 40
Zhang, T., Liu, L., Wei, L., Zeng, Y., Xu, H., Lan, Q., Su, P., & Chu, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7049 · Cited by 40
MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis
Qiu, Y., Hu, Q., Tang, Q., Feng, W., Hu, S.-J., Liang, B., Peng, W., & Yin, P. (2013) · Tumor Biology · doi:10.1007/s13277-013-1342-6 · Cited by 39
Xu, H., Zeng, Y., Liu, L., Gao, Q., Jin, S., Lan, Q., Wei, L., Luo, X., Wu, H., Huang, Y., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4090 · Cited by 39
Fang, C., Fan, C., Wang, C., Huang, Q., Meng, W., Yu, Y., Yang, L., Hu, J., Li, Y., Mo, X., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1241 · Cited by 39
Role of HGF/c‐Met in the treatment of colorectal cancer with liver metastasis
Yao, J., Li, X., Yan, L., He, S., Zheng, J., Wang, X., Zhou, P., Zhang, L., Wei, G., & Sun, X. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22316 · Cited by 39
Lam, C. S.-C., Ng, L., Chow, A. K.-M., Wan, T. M.-H., Yau, S., Cheng, N. S.-M., Wong, S. K., Man, J. H.-W., Lo, O. S., Foo, C. C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15844 · Cited by 38
Hu, H., Wang, M., Wang, H., Liu, Z., Guan, X., Yang, R., Huang, R., Tang, Q., Zou, C., Wang, G., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489374 · Cited by 38
Self-citationMicroRNA-30b-5p functions as a metastasis suppressor in colorectal cancer by targeting Rap1b
Fan, M., Ma, X., Wang, F., Zhou, Z., Zhang, J., Zhou, D., Hong, Y., Wang, Y., Wang, G., & Dong, Q. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.021 · Cited by 38
Self-citationLiu, J., Cho, Y. B., Hong, H. K., Wu, S., Ebert, P. J., Bray, S. M., Wong, S. S., Ting, J. C., Calley, J. N., Whittington, C. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67842-5 · Cited by 38
FBX8 promotes metastatic dormancy of colorectal cancer in liver
Zhu, X., Wang, F., Wu, X., Zhou, L., Wang, Z., Ren, X., Zhou, Y., Song, F., Liang, Y., Zeng, Z., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02870-7 · Cited by 37
Wu, J., Li, H., Xie, H., Wu, X., & Lan, P. (2019) · Carcinogenesis · doi:10.1093/carcin/bgy138 · Cited by 36
Schelter, F., Halbgewachs, B., Baeumler, P. I., Neu, C., Görlach, A., Schrötzlmair, F., & Krüger, A. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9360-x · Cited by 36
Xie, Y., Zhao, J., Liang, Y., Chen, M., Luo, Y., Cui, X., Jiang, B., Peng, L., & Wang, X. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1606006 · Cited by 36
Picardo, F., Romanelli, A., Muinelo‐Romay, L., Mazza, T., Fusilli, C., Parrella, P., Barbazán, J., López‐López, R., Barbano, R., Robertis, M. D., et al. (2019) · Cancers · doi:10.3390/cancers11101598 · Cited by 36
Organ, S. L., Tong, J., Taylor, P. P., St‐Germain, J. R., Navab, R., Moran, M. F., & Tsao, M. (2011) · Journal of Proteome Research · doi:10.1021/pr200238t · Cited by 35
Liu, W., Jing, Y., Yan, F., Han, Z., Lai, F., Zeng, J., Yu, G., Fan, Q., Li, R., Zhao, Q., et al. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1134404 · Cited by 35
Hong, S., Yan, Z., Song, Y., Bi, M., & Li, S. (2020) · Aging · doi:10.18632/aging.102940 · Cited by 35
Cho, W.-C., Kim, M. J., Park, J. W., Jeong, S., & Ku, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.101000 · Cited by 35
Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis
Ye, L., Ren, L., Qiu, J., Zhu, D., Chen, T., Chang, W., Lv, S., & Xu, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3627-4 · Cited by 34
The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer
Wang, Z., Zhou, L., Wang, Y., Peng, Q., Li, H., Zhang, X., Su, Z., Song, J., Sun, Q., Sayed, S., et al. (2021) · Theranostics · doi:10.7150/thno.53901 · Cited by 34
Self-citationWatanabe, T. (1994) · Oncology Reports · doi:10.3892/or_00000068 · Cited by 33
Zhong, L., Simoneau, B., Huot, J., & Simard, M. J. (2016) · Oncotarget · doi:10.18632/oncotarget.13779 · Cited by 33
Huang, L., Ma, L., Xuan, W., Zhen, X., Zheng, H., Chen, W., & Hamblin, M. R. (2019) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2019.2829 · Cited by 33
Self-citationQi, Z., Yalikong, A., Zhang, J., Cai, S., Li, B., Di, S., Lv, Z., Xu, E., Zhong, Y., & Zhou, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16186 · Cited by 33
Abdalla, E. K. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.06.029 · Cited by 31
Zheng, C., Chen, R., Xie, J.-B., Liu, C., Jin, Z., & Jin, C. (2015) · Cancer Biomarkers · doi:10.3233/cbm-150533 · Cited by 31
Zhang, Z., Bu, X., Yang, J., Zhu, S., He, S., Zheng, J., Wang, W., & Chu, D. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26619 · Cited by 31
Liao, H., Ahmed, M., Markezana, A., Zeng, G.-H., Stechele, M., Galun, E., & Goldberg, S. N. (2019) · Radiology · doi:10.1148/radiol.2019191023 · Cited by 31
Zhu, X., Bu, F., Tan, T., Luo, Q., Zhu, J., Kang, L., Huang, J., Luo, C. H., & Zhu, Z. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01717-5 · Cited by 31
Chen, H., Jiang, Y., Lin, C.-M., Tsai, S., Peng, S., Fushiya, S., Hour, M., & Yang, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1941 · Cited by 30
Zhang, A., Shen, Q., & Zhang, P. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s114609 · Cited by 30
Xiao, B., Zhang, L., Liu, H., Fang, H., Wang, C., Huang, B., Liu, X., Zhou, X., & Wang, Y. (2020) · Biomedicines · doi:10.3390/biomedicines8120593 · Cited by 30
Self-citationJin, L., Pan, Y., Zhang, J., & Cao, P.-G. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101036 · Cited by 30
Wang, Q., Feng, M., Yu, T., Liu, X.-S., & Zhang, P. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.01.002 · Cited by 29
Willenbacher, E., Khan, S. Z., Altuna, S. C., Trapani, D., Hussain, S., Wolf, D. G. F., Willenbacher, W., Spizzo, G., & Seeber, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165725 · Cited by 29
Hata, T., Mokutani, Y., Takahashi, H., Inoue, A., Munakata, K., Nagata, K., Haraguchi, N., Nishimura, J., Hata, T., Matsuda, C., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3813 · Cited by 28
Malvicini, M., Gutiérrez‐Moraga, A., Rodríguez, M. M., Gomez-Bustillo, S., Salazar, L., Sunkel, C. E., Nozal, L., Salgado, A., Hidalgo, M. M., Lopez-Casas, P. P., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0193 · Cited by 27
Wang, Y., Alkhaldi, N. D., Pandey, N. K., Chudal, L., Wang, L. Y., Lin, L., Zhang, M., Yong, Y. X., Amador, E. H., Huda, M. N., et al. (2021) · Materials Today Physics · doi:10.1016/j.mtphys.2021.100435 · Cited by 27
Self-citationPohl, M., & Schmiegel, W. (2016) · Digestive Diseases · doi:10.1159/000445267 · Cited by 26
Wu, H., Huang, S., Lu, C.-G., Shao-dong, T., & Chen, M. (2020) · PubMed Central · Cited by 26
Dahlmann, M., Sack, U., Herrmann, P., Lemm, M., Fichtner, I., Schlag, P. M., & Stein, U. (2012) · Oncotarget · doi:10.18632/oncotarget.572 · Cited by 25
Flagged first, then by citations
Research works printed but not linked: 1
- Ma, L., Zou, X., Chen, W. & New, A. X-ray Induced Nanoparticle Photosensitizers For Cancer Treatment. J. Biomed. Nanotechnol. 10, 1501–1508 (2014). · DOI
Cited by
Sorted by citations
Advances in single-cell RNA sequencing and its applications in cancer research
Huang, D., Ma, N., Li, X., Gou, Y., Duan, Y., Liu, B., Xia, J., Zhao, X., Wang, X., Li, Q., et al. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01494-6 · Cited by 224
IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction
Shiri, A. M., Zhang, T., Bedke, T., Zazara, D. E., Zhao, L., Lücke, J., Sabihi, M., Fazio, A., Zhang, S., Tauriello, D. V. F., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.12.015 · Cited by 142
Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
Underwood, P. W., Ruff, S. M., & Pawlik, T. M. (2024) · Cells · doi:10.3390/cells13030245 · Cited by 130
Nano-enabled colorectal cancer therapy
Pan, Q., Xi, F., Xie, L. W., Wu, D., Liu, R., Gao, W., Luo, K., He, B., & Pu, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.014 · Cited by 93
Li, Y., Yuan, R., Luo, Y., Guo, X., Yang, G., Li, X., & Zhou, S. (2023) · Advanced Materials · doi:10.1002/adma.202300216 · Cited by 81
Metadata
- Authors
- Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., & Wen, Y.
- Affiliations
- Central South University (CN)
- The University of Texas at Arlington (US)
- Sichuan University (CN)
- Corresponding author
- Xiong, Li
- Chen, Wei
- Wen, Yu
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2022-03-04
- Volume
- 7
- Issue
- 1
- Pages
- 70-70
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC8897452
- OpenAlex
- W4214924743
- Cited by
- 298
- References
- 435
- Citations by year
- 2026: 55 · 2025: 99 · 2024: 68 · 2023: 60 · 2022: 16
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Texas at Arlington
- National Natural Science Foundation of China (82000756, 81873640, 81970569, 81773293)
- Hunan Provincial Science and Technology Department (2017WK2063, 2015GK3117)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- colorectal liver metastases, colorectal cancer, molecular mechanisms, tumor microenvironment, targeted therapy, diagnosis, treatment, prognosis
- MeSH terms
- Humans, Liver Neoplasms, Colorectal Neoplasms, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review